6,6'-dicorynomycolyl trehalose has been researched along with lipid a in 10 studies
| Studies (6,6'-dicorynomycolyl trehalose) | Trials (6,6'-dicorynomycolyl trehalose) | Recent Studies (post-2010) (6,6'-dicorynomycolyl trehalose) | Studies (lipid a) | Trials (lipid a) | Recent Studies (post-2010) (lipid a) |
|---|---|---|---|---|---|
| 27 | 1 | 7 | 3,901 | 125 | 1,143 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 7 (70.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McGee, JM; Patten, MR; Price, JA; Snyder, D | 1 |
| Cease, KB; Hankenson, FC; Oscherwitz, J; Yu, F | 1 |
| Berhanu, A; Brown, LL; Grosenbach, DW; Honeychurch, KM; Hruby, DE; Jones, KF; King, DS; Kirkwood-Watts, DL; Krupkin, AK; Lund, SA; Vandermay, E; Warren, TK; Weimers, W; Wilson, RL | 1 |
| Acquafredda, A; Brandonisio, O; Fasanella, A; Gradoni, L; Mitolo, V; Panaro, MA; Scaltrito, D; Trotta, T | 1 |
| Ali, N; Bhowmick, S; Das, A; Ravindran, R | 1 |
| Ali, N; Maji, M; Ravindran, R | 1 |
| Ali, N; Maji, M; Mazumder, S | 1 |
| Ali, N; Das, A | 1 |
| Bolduc, DL; Elliott, TB; Fatanmi, OO; Kiang, JG; Ledney, GD; Newman, VL; Romaine, PL; Singh, VK; Wise, SY | 1 |
| Dyevoich, AM; Haas, KM; Haro, MA; Phipps, JP | 1 |
1 trial(s) available for 6,6'-dicorynomycolyl trehalose and lipid a
| Article | Year |
|---|---|
Comparison between three adjuvants for a vaccine against canine leishmaniasis: In vitro evaluation of macrophage killing ability.
Topics: Adjuvants, Immunologic; Animals; Antigens, Protozoan; BCG Vaccine; Cell Wall Skeleton; Cord Factors; Dog Diseases; Dogs; Female; Humans; Leishmania infantum; Leishmaniasis; Leishmaniasis Vaccines; Leukocytes, Mononuclear; Lipid A; Macrophages; Male; Time Factors | 2010 |
9 other study(ies) available for 6,6'-dicorynomycolyl trehalose and lipid a
| Article | Year |
|---|---|
Effects of the adjuvant MPL + TDM on tumor challenge in the B16 mouse melanoma model.
Topics: Adjuvants, Immunologic; Animals; Cord Factors; Lipid A; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Tumor Cells, Cultured | 1996 |
Low-dose intraperitoneal Freund's adjuvant: toxicity and immunogenicity in mice using an immunogen targeting amyloid-beta peptide.
Topics: Adjuvants, Immunologic; Alum Compounds; Alzheimer Vaccines; Amyloid beta-Peptides; Animals; Antibodies; Body Weight; Cord Factors; Female; Freund's Adjuvant; Injections, Intraperitoneal; Leukocyte Count; Lipid A; Mice; Mice, Inbred C57BL; Models, Animal; Spleen | 2006 |
Vaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge.
Topics: Adjuvants, Immunologic; Animals; Antibodies, Viral; Cord Factors; Epitopes, B-Lymphocyte; Escherichia coli; Female; Humans; Interferon-gamma; Lipid A; Lymphocytes; Membrane Glycoproteins; Membrane Proteins; Mice; Mice, Inbred BALB C; Neutralization Tests; Poloxalene; Smallpox; Smallpox Vaccine; Spleen; Survival Analysis; Vaccines, Subunit; Vaccinia virus; Viral Envelope Proteins; Viral Proteins; Viral Structural Proteins | 2008 |
Comparison of BCG, MPL and cationic liposome adjuvant systems in leishmanial antigen vaccine formulations against murine visceral leishmaniasis.
Topics: Adjuvants, Immunologic; Animals; Antibodies, Protozoan; Antigens, Protozoan; BCG Vaccine; Cord Factors; Female; Immunity, Humoral; Leishmaniasis Vaccines; Leishmaniasis, Visceral; Lipid A; Mice; Time Factors | 2010 |
Vaccination with liposomal leishmanial antigens adjuvanted with monophosphoryl lipid-trehalose dicorynomycolate (MPL-TDM) confers long-term protection against visceral leishmaniasis through a human administrable route.
Topics: Adjuvants, Immunologic; Animals; Antigens, Protozoan; Cells, Cultured; Chemical Phenomena; Cord Factors; Immunity, Active; Immunity, Cellular; Immunologic Memory; Injections, Subcutaneous; Interferon-gamma; Interleukin-4; Leishmania donovani; Leishmaniasis Vaccines; Leishmaniasis, Visceral; Lipid A; Liposomes; Liver; Mice; Mice, Inbred BALB C; Phospholipids; Specific Pathogen-Free Organisms; Spleen | 2012 |
Potentiating effects of MPL on DSPC bearing cationic liposomes promote recombinant GP63 vaccine efficacy: high immunogenicity and protection.
Topics: Adjuvants, Immunologic; Animals; Cord Factors; Cytokines; Disease Models, Animal; Female; Humans; Injections, Subcutaneous; Leishmania donovani; Leishmaniasis Vaccines; Leishmaniasis, Visceral; Lipid A; Liposomes; Metalloendopeptidases; Mice; Mice, Inbred BALB C; Nitric Oxide; Phosphatidylcholines; Th1 Cells; Vaccination; Vaccines, Synthetic | 2011 |
Combining cationic liposomal delivery with MPL-TDM for cysteine protease cocktail vaccination against Leishmania donovani: evidence for antigen synergy and protection.
Topics: Animals; Antigens, Protozoan; Cations; Cord Factors; Cricetinae; Cysteine Proteases; Disease Models, Animal; Drug Delivery Systems; Leishmania donovani; Leishmaniasis; Lipid A; Liposomes; Mesocricetus; Protozoan Vaccines | 2014 |
Combined immunomodulator and antimicrobial therapy eliminates polymicrobial sepsis and modulates cytokine production in combined injured mice.
Topics: Amoxicillin; Animals; Anti-Infective Agents; Bacterial Infections; Chemokines; Cord Factors; Cytokines; Disease Models, Animal; Drug Therapy, Combination; Female; Gamma Rays; Growth Substances; Immunologic Factors; Levofloxacin; Lipid A; Mice; Radiation Injuries, Experimental; Sepsis; Skin; Wound Infection | 2015 |
Activation of B-1 Cells Promotes Tumor Cell Killing in the Peritoneal Cavity.
Topics: Animals; B-Lymphocyte Subsets; Cord Factors; Female; Immunity, Innate; Immunoglobulin M; Lectins, C-Type; Lipid A; Lymphocyte Activation; Male; Mammary Neoplasms, Animal; Mice; Mice, Inbred A; Mice, Inbred C57BL; Peritoneal Cavity; Peritoneal Neoplasms; Toll-Like Receptors | 2019 |